68Ga-PSMA-11 PET has the potential to improve patient selection for extended pelvic lymph node dissection in intermediate to high-risk prostate cancer

被引:0
|
作者
Daniela A. Ferraro
Urs J. Muehlematter
Helena I. Garcia Schüler
Niels J. Rupp
Martin Huellner
Michael Messerli
Jan Hendrik Rüschoff
Edwin E. G. W. ter Voert
Thomas Hermanns
Irene A. Burger
机构
[1] University Hospital Zurich,Department of Nuclear Medicine
[2] University of Zurich,Institute of Diagnostic and Interventional Radiology
[3] University Hospital Zurich,Department of Radiation Oncology
[4] University of Zurich,Department of Pathology and Molecular Pathology
[5] University Hospital Zurich,Department of Urology
[6] University of Zurich,Department of Nuclear Medicine
[7] University Hospital Zurich,undefined
[8] University of Zurich,undefined
[9] University Hospital Zurich,undefined
[10] University of Zurich,undefined
[11] Kantonsspital Baden,undefined
关键词
SUV; PET quantification; Lymph node metastases; PET/MR; PET/CT; Staging; Prediction model; Nomogram; Net benefit;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:147 / 159
页数:12
相关论文
共 50 条
  • [11] Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
    Daniela A. Ferraro
    Helena I. Garcia Schüler
    Urs J. Muehlematter
    Daniel Eberli
    Julian Müller
    Alexander Müller
    Roger Gablinger
    Helmut Kranzbühler
    Aurelius Omlin
    Philipp A. Kaufmann
    Thomas Hermanns
    Irene A. Burger
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 652 - 664
  • [12] Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer
    Ferraro, Daniela A.
    Schueler, Helena I. Garcia
    Muehlematter, Urs J.
    Eberli, Daniel
    Mueller, Julian
    Muller, Alexander
    Gablinger, Roger
    Kranzbuehler, Helmut
    Omlin, Aurelius
    Kaufmann, Philipp A.
    Hermanns, Thomas
    Burger, Irene A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 652 - 664
  • [13] Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer
    Wyler, Stephen F.
    Sulser, Tullio
    Seifert, Hans-Helge
    Ruszat, Robin
    Forster, Thomas H.
    Gasser, Thomas C.
    Bachmann, Alexander
    UROLOGY, 2006, 68 (04) : 883 - 887
  • [14] Can patient selection based on 68Ga-PSMA-11 PET improve the outcome of radical prostatectomy in prostate cancer patients?
    Burger, I. A.
    Ferraro, D. A.
    Muehlematter, U. J.
    Schuler, H. I. Garcia
    Eberli, D.
    Hermanns, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S448 - S449
  • [15] Primary lymph-node staging with 68Ga-PSMA PET in high-risk prostate cancer: pathologic correlation with extended pelvic lymphadenectomy specimens
    Corona-Montes, V. E.
    Gonzalez-Cuenca, E.
    Fernandez-Noyola, G.
    Olarte-Casas, M. A.
    Bobadilla-Salazar, D.
    Medrano-Urtecho, H. M.
    Asimakopoulos, A. D.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (08) : 494.e1 - 494.e6
  • [16] Comparison of staging using [68Ga]Ga-PSMA-11 PET/CT and histopathological results in intermediate- and high-risk prostate cancer patients treated with radical prostatectomy and pelvic lymph node dissection
    Rosales, J. J.
    Antar, V. Betech
    Minguez, F.
    Pareja, F.
    Guillen, F.
    Prieto, E.
    Quincoces, G.
    Caballero, F. Diez
    Minana, B.
    Perez-Gracia, J. L.
    Rodriguez-Fraile, M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (02):
  • [17] 68Ga-PSMA-11 PET accuracy in recurrent prostate cancer
    Telo, Silvi
    Farolfi, Andrea
    Castellucci, Paolo
    Fanti, Stefano
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2019, 8 (06) : 772 - 774
  • [18] CHARACTERIZING PROSTATE CANCER RISK WITH 68GA-PSMA-11 PET IMAGING AND AI
    Hacker, Marcus
    Wail, Simon
    Dolezel, Lubos
    Iommi, David
    Beyer, Thomas
    Papp, Laszlo
    JOURNAL OF UROLOGY, 2024, 211 (05): : E794 - E794
  • [19] Comparison of 18F-PSMA-1007 PET/CT With 68Ga-PSMA-11 PET/CT for Initial Staging in Intermediate- and High-Risk Prostate Cancer
    Chandekar, Kunal Ramesh
    Singh, Harmandeep
    Kumar, Rajender
    Kumar, Santosh
    Kakkar, Nandita
    Mittal, Bhagwant Rai
    Singh, Shrawan Kumar
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (01) : E1 - E8
  • [20] Head-to-Head Comparison of 68Ga-PSMA-11 PET/CT and Multiparametric MRI for Pelvic Lymph Node Staging Prior to Radical Prostatectomy in Patients With Intermediate to High-Risk Prostate Cancer: A Meta-Analysis
    Wang, Xueju
    Wen, Qiang
    Zhang, Haishan
    Ji, Bin
    FRONTIERS IN ONCOLOGY, 2021, 11